Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06FOL
|
|||
Former ID |
DIB000099
|
|||
Drug Name |
CALDARET HYDRATE
|
|||
Synonyms |
MCC-135; Caldaret hydrate; 5-Methyl-2-(1-piperazinyl)benzenesulfonic acid monohydrate
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cardiovascular disease [ICD-11: BA00-BE2Z; ICD-10: I00-I99] | Phase 2 | [1] | |
Company |
Mitsubishi Pharma
|
|||
Structure |
Download2D MOL |
|||
Formula |
C11H18N2O4S
|
|||
Canonical SMILES |
CC1=CC(=C(C=C1)N2CCNCC2)S(=O)(=O)O.O
|
|||
InChI |
1S/C11H16N2O3S.H2O/c1-9-2-3-10(11(8-9)17(14,15)16)13-6-4-12-5-7-13;/h2-3,8,12H,4-7H2,1H3,(H,14,15,16);1H2
|
|||
InChIKey |
ZRQKZWAOIRVBFD-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 192509-24-3
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sodium/calcium exchanger (SLC) | Target Info | Modulator | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Caldaret, an intracellular Ca2+ handling modulator, limits infarct size of reperfused canine heart. J Pharmacol Sci. 2007 Feb;103(2):222-33. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.